110 related articles for article (PubMed ID: 7535040)
1. Aprotinin improves hemostasis after cardiopulmonary bypass better than single-donor platelet concentrate.
Shinfeld A; Zippel D; Lavee J; Lusky A; Shinar E; Savion N; Mohr R
Ann Thorac Surg; 1995 Apr; 59(4):872-6. PubMed ID: 7535040
[TBL] [Abstract][Full Text] [Related]
2. Platelet protection by low-dose aprotinin in cardiopulmonary bypass: electron microscopic study.
Lavee J; Raviv Z; Smolinsky A; Savion N; Varon D; Goor DA; Mohr R
Ann Thorac Surg; 1993 Jan; 55(1):114-9. PubMed ID: 7678061
[TBL] [Abstract][Full Text] [Related]
3. Aprotinin prevents cardiopulmonary bypass-induced platelet dysfunction. A scanning electron microscope study.
Mohr R; Goor DA; Lusky A; Lavee J
Circulation; 1992 Nov; 86(5 Suppl):II405-9. PubMed ID: 1385010
[TBL] [Abstract][Full Text] [Related]
4. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR
J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
[TBL] [Abstract][Full Text] [Related]
5. Platelet protection by aprotinin in cardiopulmonary bypass: electron microscopic study.
Lavee J; Savion N; Smolinsky A; Goor DA; Mohr R
Ann Thorac Surg; 1992 Mar; 53(3):477-81. PubMed ID: 1371665
[TBL] [Abstract][Full Text] [Related]
6. Aprotinin effect on platelet function and clotting during cardiopulmonary bypass.
Tabuchi N; De Haan J; Boonstra PW; Huet RC; van Oeveren W
Eur J Cardiothorac Surg; 1994; 8(2):87-90. PubMed ID: 7513534
[TBL] [Abstract][Full Text] [Related]
7. Aprotinin preserves hemostasis in aspirin-treated patients undergoing cardiopulmonary bypass.
Tabuchi N; Huet RC; Sturk A; Eijsman L; Wildevuur CR
Ann Thorac Surg; 1994 Oct; 58(4):1036-9. PubMed ID: 7524460
[TBL] [Abstract][Full Text] [Related]
8. Fresh blood units contain large potent platelets that improve hemostasis after open heart operations.
Mohr R; Goor DA; Yellin A; Moshkovitz Y; Shinfeld A; Martinowitz U
Ann Thorac Surg; 1992 Apr; 53(4):650-4. PubMed ID: 1554276
[TBL] [Abstract][Full Text] [Related]
9. Combination of acute preoperative plateletpheresis, cell salvage, and aprotinin minimizes blood loss and requirement during cardiac surgery.
Li S; Ji H; Lin J; Lenehan E; Ji B; Liu J; Liu J; Long C; Crane TA
J Extra Corpor Technol; 2005 Mar; 37(1):9-14. PubMed ID: 15804151
[TBL] [Abstract][Full Text] [Related]
10. [Reduction of postoperative blood loss and donor blood use in heart surgery with aprotinin: experience with various dosages].
Carrel T; Bauer E; Garcia E; von Segesser L; Niederhäuser U; Schönbeck M; Laske A; Turina M
Helv Chir Acta; 1991 Sep; 58(3):365-78. PubMed ID: 1722785
[TBL] [Abstract][Full Text] [Related]
11. Platelet preservation during cardiopulmonary bypass with aprotinin.
Wildevuur CR; Eijsman L; Roozendaal KJ; Harder MP; Chang M; van Oeveren W
Eur J Cardiothorac Surg; 1989; 3(6):533-7; discussion 537-8. PubMed ID: 2483979
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss.
Boldt J; Knothe C; Zickmann B; Wege N; Dapper F; Hempelmann G
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):705-11. PubMed ID: 7682266
[TBL] [Abstract][Full Text] [Related]
13. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol).
Bidstrup BP; Royston D; Sapsford RN; Taylor KM
J Thorac Cardiovasc Surg; 1989 Mar; 97(3):364-72. PubMed ID: 2465457
[TBL] [Abstract][Full Text] [Related]
14. "Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release.
Ashraf S; Tian Y; Cowan D; Nair U; Chatrath R; Saunders NR; Watterson KG; Martin PG
Ann Thorac Surg; 1997 Jan; 63(1):68-73. PubMed ID: 8993243
[TBL] [Abstract][Full Text] [Related]
15. Mini-dose pump-prime aprotinin inhibited enhanced fibrinolytic activity and reduced blood loss and transfusion requirements after coronary artery bypass surgery.
Kunt AS; Darcin OT; Aydin S; Demir D; Selli C; Andac MH
J Thromb Thrombolysis; 2005 Jun; 19(3):197-200. PubMed ID: 16082607
[TBL] [Abstract][Full Text] [Related]
16. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass.
Blauhut B; Gross C; Necek S; Doran JE; Späth P; Lundsgaard-Hansen P
J Thorac Cardiovasc Surg; 1991 Jun; 101(6):958-67. PubMed ID: 1710008
[TBL] [Abstract][Full Text] [Related]
17. Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypass.
Khalil PN; Ismail M; Kalmar P; von Knobelsdorff G; Marx G
Thromb Haemost; 2004 Sep; 92(3):568-74. PubMed ID: 15351853
[TBL] [Abstract][Full Text] [Related]
18. [Aprotinin in cardiac surgery in patients with platelet anti-aggregant treatment].
Bertrand P; Mazzucotelli JP; Loisance D; Elsayed A; Deleuze P; Cachera JP
Arch Mal Coeur Vaiss; 1993 Oct; 86(10):1471-4. PubMed ID: 7516648
[TBL] [Abstract][Full Text] [Related]
19. Low-dose and high-dose aprotinin improve hemostasis in coronary operations.
Speekenbrink RG; Wildevuur CR; Sturk A; Eijsman L
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):523-30. PubMed ID: 8751522
[TBL] [Abstract][Full Text] [Related]
20. Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass.
Harder MP; Eijsman L; Roozendaal KJ; van Oeveren W; Wildevuur CR
Ann Thorac Surg; 1991 Jun; 51(6):936-41. PubMed ID: 1710098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
